Section Arrow
CSTL.NASDAQ
- Castle Biosciences
Quotes are at least 15-min delayed:2026/03/29 20:57 EDT
Regular Hours
Last
 23.53
-1.17 (-4.74%)
Day High 
24.645 
Prev. Close
24.7 
1-M High
30.495 
Volume 
294.10K 
Bid
20.68
Ask
30
Day Low
23.44 
Open
24.6 
1-M Low
24.65 
Market Cap 
734.36M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 25.47 
20-SMA 26.4 
50-SMA 32.19 
52-W High 44.28 
52-W Low 14.59 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.83/-0.22
Enterprise Value
769.53M
Balance Sheet
Book Value Per Share
15.84
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
344.23M
Operating Revenue Per Share
6.46
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DHRDanaher Corp181.52-6.13-3.27%37.31PE
OPKOPKO Health1.12-0.05-4.27%-- 
PSNLPersonalis6.34-0.98-13.39%-- 
BIAFbioAffinity Technologies Inc4-0.74-15.61%-- 
SHCSotera Health Company13.13-0.41-3.03%50.15PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.